Highlands Hospital Corp

Highlands Hospital Corp was paid $15.88M by Medicaid between Jan 2018 and Sep 2020, across 308 billing codes. Its largest line is 99285, emergency room visit (most serious) — 19% of everything it billed.

33Billing provider infoHIGHLANDS HOSPITAL CORP
PRESTONSBURG, KY 41653

33aNPI1194818138assigned 10/02/2006

33bProvider typeNurse Practitioner

28Total paid$15.88M

24GClaims405,692

24DCodes billed308

24AFirst – last monthJan 2018 – Sep 2020

Compared with peers

Next to other Nurse Practitioner providers in Kentucky

Rank by total paid#3 of 260

Median peer was paid$89K

This provider vs. median178×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	183,295	$6.64M
2019	184,320	$7.65M
2020	38,077	$1.59M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	19%	10,360	6,908	$2.97M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.9%	7,084	5,871	$1.57M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	6.8%	18,198	12,933	$1.08M
74176	Computed tomography, abdomen and pelvis; without contrast material	4.1%	3,024	2,171	$645K
74177	Computed tomography, abdomen and pelvis; with contrast material	3.1%	1,791	1,445	$495K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.1%	4,351	3,747	$488K
41899	Unlisted procedure, dentoalveolar structures	2.9%	481	424	$459K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.5%	6,344	4,668	$392K
20610		2.1%	2,600	1,903	$326K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.0%	942	704	$313K
70450	Computed tomography, head or brain; without contrast material	1.7%	2,430	1,815	$274K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.6%	1,188	602	$253K

296 more codes

93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.5%	1,241	$238K
99214	Doctor's office visit, returning patient (more involved)	1.4%	4,290	$219K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.3%	7,603	$206K
80053	Comprehensive metabolic panel	1.3%	32,664	$200K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.3%	5,165	$199K
71045	Radiologic examination, chest; single view	1.2%	8,486	$185K
99213	Doctor's office visit, returning patient (routine)	1.1%	5,494	$175K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	507	$154K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	149	$153K
G0379	Direct admission of patient for hospital observation care	<1%	164	$148K
G0378	Hospital observation service, per hour	<1%	2,800	$143K
96361	Intravenous infusion, hydration; each additional hour	<1%	3,574	$132K
72131		<1%	833	$130K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	531	$126K
59025	Fetal non-stress test	<1%	1,531	$118K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	22,292	$113K
71046	Radiologic examination, chest; 2 views	<1%	3,431	$109K
72125	Computed tomography, cervical spine; without contrast material	<1%	646	$108K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	424	$107K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,090	$96K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	697	$96K
20550		<1%	857	$89K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	1,274	$88K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,301	$86K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	6,122	$85K
99218		<1%	595	$80K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	229	$77K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,060	$77K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,389	$75K
71250		<1%	840	$74K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,639	$73K
76536		<1%	963	$72K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	1,283	$68K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	9,271	$68K
84443	Thyroid stimulating hormone (TSH)	<1%	4,811	$66K
71275	Computed tomographic angiography, chest, with contrast material	<1%	378	$54K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,322	$53K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,932	$53K
70486		<1%	409	$52K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,450	$50K
80061	Lipid panel	<1%	4,317	$50K
73564		<1%	1,763	$49K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,648	$48K
93225		<1%	412	$45K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	82	$42K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	6,177	$39K
36415	Collection of venous blood by venipuncture	<1%	17,201	$38K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	855	$36K
73610		<1%	1,460	$35K
73110		<1%	1,382	$35K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	5,421	$35K
73030		<1%	1,447	$34K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	14	$34K
93017		<1%	670	$34K
73130		<1%	1,177	$33K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,350	$31K
82607		<1%	2,610	$31K
77065	Tomosynthesis, mammo	<1%	604	$30K
93971		<1%	386	$29K
73630		<1%	1,143	$29K
80048	Basic metabolic panel (calcium, ionized)	<1%	5,090	$28K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,535	$27K
72141		<1%	102	$27K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	154	$27K
84484		<1%	4,561	$27K
97162		<1%	508	$27K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	500	$27K
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,680	$26K
20551		<1%	431	$26K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	5,143	$25K
80074		<1%	621	$25K
76775		<1%	409	$24K
82550		<1%	3,809	$23K
87086	Culture, bacterial; quantitative colony count, urine	<1%	4,481	$22K
99203	Doctor's office visit, new patient (routine)	<1%	638	$22K
72110		<1%	410	$22K
J2704	Injection, propofol, 10 mg	<1%	1,963	$21K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	75	$21K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,730	$20K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	43	$20K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	507	$20K
97014		<1%	1,940	$20K
83880		<1%	1,173	$18K
99051		<1%	2,546	$18K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	38	$18K
97161		<1%	321	$17K
87902		<1%	72	$17K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	179	$17K
80306		<1%	1,786	$16K
73080		<1%	652	$16K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	454	$16K
76642		<1%	232	$16K
83690		<1%	4,076	$15K
88304		<1%	596	$15K
84703		<1%	3,636	$15K
87522	Neg quan hep c or qual rna	<1%	403	$15K
74018		<1%	676	$14K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	291	$13K
93226		<1%	311	$13K
81001		<1%	5,340	$12K
82150		<1%	3,772	$12K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	553	$12K
73502		<1%	630	$12K
97164		<1%	415	$12K
87496		<1%	552	$12K
84436		<1%	1,902	$11K
87581		<1%	523	$11K
87040		<1%	1,828	$11K
36600		<1%	1,058	$11K
77066	Tomosynthesis, mammo	<1%	169	$11K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	2,060	$10K
73562		<1%	550	$10K
J7050	Infusion, normal saline solution, 250 cc	<1%	1,956	$10K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,527	$9K
73590		<1%	394	$9K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	450	$9K
84702		<1%	1,098	$9K
84479		<1%	1,470	$9K
82746		<1%	941	$9K
83735		<1%	1,781	$8K
96376		<1%	736	$8K
73090		<1%	339	$8K
81003		<1%	4,888	$8K
97012		<1%	717	$7K
52000		<1%	37	$7K
86677		<1%	830	$7K
85610		<1%	2,324	$7K
C1769	Guide wire	<1%	172	$7K
86900		<1%	1,037	$7K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	459	$7K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	1,178	$7K
29075		<1%	73	$7K
87077		<1%	1,438	$7K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	137	$6K
87186		<1%	1,076	$6K
70491		<1%	37	$6K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,580	$6K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	779	$6K
88342		<1%	230	$6K
82803		<1%	494	$6K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	247	$6K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,887	$6K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	1,612	$6K
74021		<1%	192	$5K
87807		<1%	1,041	$5K
83605		<1%	687	$5K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	292	$5K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,228	$5K
85379		<1%	939	$5K
86140		<1%	1,308	$5K
84439		<1%	653	$5K
87070		<1%	878	$5K
J1815	Injection, insulin, per 5 units	<1%	620	$5K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,813	$5K
87900		<1%	41	$5K
86850		<1%	1,009	$5K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	173	$5K
72128		<1%	27	$4K
86038		<1%	413	$4K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,904	$4K
97116		<1%	327	$4K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	155	$4K
85730		<1%	1,290	$4K
83540		<1%	753	$4K
85651		<1%	1,201	$4K
83550		<1%	554	$4K
95911		<1%	15	$4K
86592		<1%	786	$4K
10060		<1%	19	$4K
99204	Doctor's office visit, new patient (more involved)	<1%	29	$3K
82728		<1%	368	$3K
43450		<1%	12	$3K
74178		<1%	20	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	425	$3K
81000		<1%	918	$3K
76641		<1%	30	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	257	$2K
86901		<1%	958	$2K
86738		<1%	315	$2K
29705		<1%	23	$2K
72052		<1%	33	$2K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	41	$2K
80348		<1%	256	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	143	$2K
72083		<1%	14	$2K
J2785	Injection, regadenoson, 0.1 mg	<1%	27	$2K
84550		<1%	626	$2K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	352	$2K
82977		<1%	262	$2K
77002		<1%	46	$2K
77080		<1%	51	$2K
25600		<1%	15	$2K
82172		<1%	99	$2K
83883		<1%	161	$1K
80069		<1%	321	$1K
82247		<1%	352	$1K
93041		<1%	173	$1K
93922		<1%	42	$1K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	148	$1K
80050	General health panel	<1%	488	$1K
83010		<1%	100	$1K
51701		<1%	76	$1K
82553		<1%	245	$1K
83615		<1%	303	$1K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	13	$1K
83655		<1%	76	$969.76
72072		<1%	34	$967.87
87205		<1%	430	$962.55
76830	Ultrasound, transvaginal	<1%	14	$937.63
81002		<1%	337	$875.37
82043		<1%	165	$840.24
91200		<1%	14	$803.16
74230		<1%	18	$794.59
82140		<1%	92	$757.88
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	591	$749.10
86235		<1%	14	$726.44
73521		<1%	30	$717.96
J0690	Injection, cefazolin sodium, 500 mg	<1%	256	$692.12
86308		<1%	229	$690.03
80337		<1%	203	$664.11
J3490	Unclassified drugs	<1%	176	$660.29
90686		<1%	47	$635.78
80076		<1%	99	$566.55
82948		<1%	285	$518.87
99406		<1%	43	$500.42
88307		<1%	12	$490.35
80349		<1%	58	$489.72
51798		<1%	33	$488.71
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	111	$486.42
J1956	Injection, levofloxacin, 250 mg	<1%	60	$481.80
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	12	$474.28
51702		<1%	27	$463.17
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	100	$458.54
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	45	$435.71
80359		<1%	171	$435.46
84460		<1%	101	$417.27
99201		<1%	20	$407.84
29125		<1%	15	$388.14
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	30	$382.50
80324		<1%	46	$381.59
A9270	Non-covered item or service	<1%	1,516	$374.92
73552		<1%	30	$363.75
80364		<1%	151	$243.13
80331		<1%	151	$240.08
96127		<1%	47	$236.31
80334		<1%	151	$231.93
80355		<1%	151	$230.81
83992		<1%	151	$225.61
84481		<1%	12	$225.40
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	44	$222.25
80370		<1%	151	$219.52
80347		<1%	151	$213.77
80338		<1%	151	$210.65
80346		<1%	27	$206.99
80344		<1%	151	$206.83
80341		<1%	151	$203.02
80326		<1%	151	$199.97
80358		<1%	170	$198.39
80361		<1%	176	$195.69
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	28	$192.66
80372		<1%	151	$183.64
80354		<1%	151	$179.04
80356		<1%	151	$179.04
80373		<1%	151	$179.04
80365		<1%	157	$179.02
80367		<1%	151	$179.02
80377		<1%	151	$175.56
80368		<1%	151	$173.30
84153		<1%	12	$171.68
80366		<1%	151	$169.73
80353		<1%	151	$153.42
84156		<1%	75	$151.82
80357		<1%	151	$150.69
80360		<1%	151	$132.42
80371		<1%	151	$132.42
87045		<1%	41	$123.37
87046		<1%	33	$123.37
87209		<1%	13	$112.73
82248		<1%	27	$111.12
82784		<1%	44	$107.09
87324		<1%	15	$75.18
87449		<1%	15	$75.18
36000		<1%	31	$67.74
82010		<1%	13	$61.14
J1170	Injection, hydromorphone, up to 4 mg	<1%	13	$60.67
87177		<1%	13	$55.83
82272		<1%	27	$42.56
Q4012	Cast supplies, short arm cast, pediatric (0-10 years), fiberglass	<1%	25	$30.53
J7510	Prednisolone oral, per 5 mg	<1%	15	$12.56
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	493	$1.41
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	101	$0.28
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	88	$0.00
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	0%	68	$0.00
99000		0%	15	$0.00
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	0%	67	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBLACKWELL, JACK (CFO)